Exact Sciences
EXAS
#1763
Rank
$9.52 B
Marketcap
$51.48
Share price
-3.29%
Change (1 day)
-13.86%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total debt

Total debt on the balance sheet as of June 2024 : $2.76 Billion USD

According to Exact Sciences's latest financial reports the company's total debt is $2.76 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Exact Sciences - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$2.55 B4.41%
2022-12-31$2.44 B2.72%
2021-12-31$2.38 B2.21%
2020-12-31$2.33 B144.04%
2019-12-31$0.95 B38.56%
2018-12-31$0.68 B15385.31%
2017-12-31$4.45 M-18.97%
2016-12-31$5.49 M-8.69%
2015-12-31$6.01 M102.29%
2014-12-31$2.97 M-31.88%
2013-12-31$4.36 M113.6%
2012-12-31$2.04 M104.4%
2011-12-31$1 M0%
2010-12-31$1 M-49.7%
2009-12-31$1.98 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
$0.14 B-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$20.73 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.59 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.46 B 821.94%๐Ÿ‡ซ๐Ÿ‡ท France